APM
TYRA icon

Avidity Partners Management’s Tyra Biosciences TYRA Stock Holding History

Avidity Partners Management’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-373,000
Closed -$5.96M – 101
2024
Q2 		$5.96M Buy
+373,000
New +$6.42M 0.25% 68

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $76.1M AUM 638.59% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Avidity Partners Management's TYRA Position: Q3 2024 in Review

Avidity Partners Management sold out of Tyra Biosciences (TYRA) in Q3 2024, closing a stake of 373,000 shares — an estimated $5.96M sold.

Avidity Partners Management first reported a position in TYRA in Q2 2024 and held it in 1 quarter. The position peaked at $5.96M in Q2 2024. 95 funds tracked by Wall St. Rank hold TYRA as of Q3 2024.

  • Avidity Partners Management reported no remaining Tyra Biosciences position as of Q3 2024 after selling out during the quarter.
  • Avidity Partners Management sold 373,000 Tyra Biosciences shares in Q3 2024, an estimated $5.96M.
  • Avidity Partners Management first reported a position in Tyra Biosciences in Q2 2024 and held it in 1 quarter.
  • Avidity Partners Management's Tyra Biosciences position peaked at $5.96M in Q2 2024.
  • 95 funds tracked by Wall St. Rank held Tyra Biosciences as of Q3 2024.

Based on Avidity Partners Management's 13F filing for Q3 2024, filed 14 Nov 2024.